Intelligence Β· Patent portfolio
NORTHWEST BIOTHERAPEUTICS Patents
Full USPTO pharma patent portfolio for NORTHWEST BIOTHERAPEUTICS β grant dates, expiration, and drug cross-links.
- Patents
- 595
- Expiring β€24m
- 13
Quick answer
NORTHWEST BIOTHERAPEUTICS has 595 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 13 expire within 24 months β use filters for patent-cliff planning.
-
US 7470790
Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
granted -
US 7452679
Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
granted -
US 7381748
Compounds and related methods for inhibition of gamma-aminobutyric acid aminotransferase
granted -
US 7371719
Self-assembly of peptide-amphiphile nanofibers under physiological conditions
granted -
US 7335382
Compositions and methods for the treatment and prevention of cancer
granted -
US 7329775
Compounds and related methods for mutant p53 reactivation
granted -
US 7279326
Composition for delivery of a mitochondrial genome to a cell
granted -
US 7270960
Diagnosis of ovarian carcinomas
granted -
US 7271186
Nanomolar Ξ²-lactamase inhibitors
granted -
US 7208171
Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation
granted -
US 7160868
Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
granted -
US 7144867
Anticancer glycoside compounds
granted -
US 7118747
AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
granted -
US 7105496
Methods and compositions for inhibiting angiogenesis
granted -
US 7087715
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
granted -
US 6936448
Nucleic acids and proteins of a rat ganglioside GM1-specific Ξ±1-2fucosyltransferase and uses thereof
expired -
US 6919309
Methods and compositions for inhibiting angiogenesis
expired -
US 6889145
Three-dimensional model of a Fc region of an IgE antibody and uses thereof
expired -
US 6887845
Polypeptoid pulmonary surfactants
expired -
US 6863887
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
expired -
US 6803486
Selective neuronal nitric oxide synthase inhibitors
expired -
US 6797691
Methods and compositions for inhibiting angiogenesis
expired -
US 6794413
Compounds and related methods for inhibition of &ggr;-aminobutyric acid aminotransferase
expired -
US 6780984
Method for prognosing cancer and the proteins involved
expired -
US 6734172
Surface receptor antigen vaccines
expired -
US 6699481
Peptides for inhibition of herpes simplex virus entry
expired -
US 6677306
Chondrogenic and osteogenic inducing molecule
expired -
US 6670333
Methods and compositions for inhibiting angiogenesis
expired -
US 6656714
Nucleic acids and proteins of a rat ganglioside GM1-specific &agr;1→2 fucosyltransferase and uses thereof
expired -
US 6641818
Cellular proteins which mediate herpesvirus entry
expired -
US 6579857
Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
expired -
US 6576609
Methods and compositions for generating angiostatin
expired -
US 6573058
Antibody to herpes virus entry receptor protein
expired -
US 6559128
Inhibitors of G protein-mediated signaling, methods of making them, and uses thereof
expired -
US 6525096
GABA and L-glutamic acid analogs for antiseizure treatment
expired -
US 6468537
Localization of major peptide autoepitopes for nucleosome specific T cells of systemic lupus erythematosus
expired -
US 6448238
Inhibitors of &bgr;-lactamases and uses therefor
expired -
US 6444431
Angiostatin receptor
expired -
US 6417174
Inhibitors of &bgr;-lactamases and uses therefor
expired -
US 6414024
GABA and L-glutamic acid analogs for antiseizure treatment
expired -
US 6391850
Methods and compositions for inhibiting angiogenesis
expired -
US 6372713
Anti-depressant effects of corticotropin release inhibiting factor
expired -
US 6359169
GABA and L-glutamic acid analogs for antiseizure treatment
expired -
US 6348571
Corticotropin release inhibiting factor and methods of using same
expired -
US 6342529
GABA and L-glutamic acid analogs for antiseizure treatment
expired -
US 6329170
Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1.fwdarw.2fucosyltransferase and uses thereof
expired -
US 6303336
Herpes virus entry receptor protein
expired -
US 6291526
GABA and L-glutamic acid analogs for antiseizure treatment
expired
Frequently asked questions
How many patents does NORTHWEST BIOTHERAPEUTICS have?
595 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do NORTHWEST BIOTHERAPEUTICS patents expire?
13 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory